GOVERNEUR, N.Y. – Kinney Drugs has now opened both walk-ins and appointments for a second dose of seasonal COVID-19 vaccine for eligible individuals. In October, the CDC recommended that individuals aged 65 and older and those who are moderately to severely immunocompromised receive a second dose of seasonal COVID-19 vaccine two to six months after their last dose.
Patients in one or both groups who were vaccinated against COVID in the fall may now be due for a second dose. Kinney Drugs accepts walk-ins; however, appointments are encouraged to ensure the promptest service. The COVID-19 vaccine can be co-administered with all other approved vaccines.
“CDC data show the importance of vaccination to protect people who are most at risk for severe outcomes of COVID, such as older adults and anyone with an immunocompromising condition,” said John Marraffa, president of Kinney Drugs. “We know that vaccination can restore and enhance protection against those viruses that are causing infections and hospitalizations in our region, including RSV, COVID, and influenza. And flu is spiking right now, especially in older populations. So, if patients haven’t received their flu vaccine, it’s not too late for this year. As always, our pharmacists stand ready to assist with immunizations and other healthcare needs,” he added.
Kinney Drugs expands COVID-19 vaccine access for high-risk individuals
Patients in one or both groups who were vaccinated against COVID in the fall may now be due for a second dose.
Latest
CHPA’s Health In Hand Foundation holds 10th Anniversary Gala
Over 350 industry leaders from 100 companies gathered at The Bellevue Hotel for this milestone event and a major fundraiser for the Foundation’s consumer education initiatives.
Health In Hand Foundation celebrates industry excellence at 10th Annual Gala
The evening featured the 2025 U.S. Self-Care Marketing Awards, honoring grand prize winners across seven categories as well as a People’s Choice Award recognizing the strategic innovation and marketing expertise of CHPA member companies.
Edgewell to sell feminine care business to Essity for $340 million
Closing is expected in the first quarter of 2026, pending regulatory approval.
Ahold Delhaize USA marks major omnichannel milestone
Addition of Hannaford to the platform completes multi-year rollout, advancing omnichannel growth and enhancing customer experience.